Addex Therapeutics (ADXN) Institutional Ownership → [URGENT] DO NOT Touch These AI Stocks! (From Weiss Ratings) (Ad) Free ADXN Stock Alerts $8.89 -0.56 (-5.93%) (As of 02:15 PM ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Addex Therapeutics (NASDAQ:ADXN)CurrentInstitutional OwnershipPercentage16.14%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$2.10MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$2.99M Get ADXN Insider Trade Alerts Want to know when executives and insiders are buying or selling Addex Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ADXN Institutional Buying and Selling by Quarter Ad Priority GoldThe 2024 Gold Rush: Unleashing Market PotentialWelcome to the financial rollercoaster of 2024, where inflation is persistent, stock markets are overinflated and volatile, global conflicts are intensifying, and the national debt is reaching new heights.Get your free information kit NOW, before it's too late. Addex Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/13/2024Armistice Capital LLC43,000$260K0.0%-92.0%4.343% 11/15/2023Armistice Capital LLC537,000$206K0.0%+103.4%65.328% 5/1/2023Virtu Financial LLC42,912$41K0.0%+203.8%0.334% 2/14/2023Susquehanna International Group LLP72,142$45K0.0%N/A0.561% 2/10/2023NEA Management Company LLC1,080,000$113K0.0%-80.9%8.398% 11/14/2022Armistice Capital LLC320,000$256K0.0%+26.5%2.941% 11/14/2022NEA Management Company LLC5,648,690$830K0.0%+500.0%51.923% 8/5/2022OLD Mission Capital LLC31,134$36K0.0%N/A0.286% 8/12/2021New Leaf Venture Partners L.L.C.50,000$478K0.1%N/A0.609% 8/2/2021NEA Management Company LLC180,000$17.21M0.2%N/A2.192% 5/21/2021Citadel Advisors LLC11,604$121K0.0%N/A0.141% 5/18/2021Citadel Advisors LLC11,604$121K0.0%N/A0.212% 5/12/2021 UBS Group AG2,520$26K0.0%+2,420.0%0.046% 2/16/2021Caxton Corp265,940$3.56M2.2%+1,428.6%4.862% (Data available from 1/1/2016 forward) ADXN Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ADXN shares? During the previous two years, the following institutional investors and hedge funds held shares of Addex Therapeutics shares: Armistice Capital LLC ($260K), NEA Management Company LLC ($113K), Susquehanna International Group LLP ($45K), and Virtu Financial LLC ($41K), OLD Mission Capital LLC ($36K).Learn more on ADXN's institutional investors. What percentage of Addex Therapeutics stock is owned by institutional investors? 16.14% of Addex Therapeutics stock is owned by institutional investors. Learn more on ADXN's institutional investor holdings. Which institutional investors have been buying Addex Therapeutics stock? The following institutional investors have purchased Addex Therapeutics stock in the last 24 months: NEA Management Company LLC ($4.71M), Armistice Capital LLC ($339.98K), Susquehanna International Group LLP ($72.14K), OLD Mission Capital LLC ($31.13K), and Virtu Financial LLC ($28.79K). How much institutional buying is happening at Addex Therapeutics? Institutional investors have bought a total of 5,179,290 shares in the last 24 months. This purchase volume represents approximately $80.64M in transactions. Which Addex Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Addex Therapeutics stock in the last 24 months: NEA Management Company LLC ($4.57M), and Armistice Capital LLC ($494K). How much institutional selling is happening at Addex Therapeutics? Institutional investors have sold a total of 5,062,690 shares in the last 24 months. This volume of shares sold represents approximately $60.56M in transactions. Related Companies: Molecular Templates Major Shareholders Galera Therapeutics Major Shareholders Moleculin Biotech Major Shareholders MIRA Pharmaceuticals Major Shareholders Avalo Therapeutics Major Shareholders Elevai Labs Major Shareholders ABVC BioPharma Major Shareholders Monopar Therapeutics Major Shareholders Akari Therapeutics Major Shareholders Cyclerion Therapeutics Major Shareholders This page (NASDAQ:ADXN) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersBill Clinton Backing Biden Replacement???The Freeport SocietyDoes this make you sick?Allegiance Goldis this a buy and hold stock?Tips4TradersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldTrump Reveals Conspiracy Behind Fed-Controlled Digital Currency.Monetary GoldForget the “Magnificent 7” Tech Companies, Buy This AI Stock InsteadBanyan Hill PublishingTop 5 Tech Stocks to Buy for 2024Daily Market Alerts Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Addex Therapeutics Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.